About this trial
The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \[a single bolos of HCG combined with two successive doses of a GnRH agonist \] with HCG \[a single bolos administered 36 hours before oocyte retrieval \] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
GnRH antagonist IVF cycle
Normo-responders to induction of ovulation
Disqualifiers
Hypogonadotrophic hypogonadism
Endometriosis
History of recurrent abortion
Trial design
Parallel
Treatments tested in this trial
Modified dual trigger
DrugHCG (10000 IU /IM) and triptorelin (0.2 mg/S.C) are administered 36 hours before ovum pickup . Moreover, 0.1mg of triptorelin is administered 24 h prior to ovum pick-up.
HCG
DrugHCG (10000 IU/IM ) is administered 36 hours before ovum pickup.
Treatment groups
Trial outcomes
Primary outcomes
Metaphase-II oocytes rate
Number of MII oocyte/ number of cumulus oocyte complex
Secondary outcomes
Clinical pregnancy rate
Presence of intrauterine gestational sac detected by transvaginal ultrasound
Ongoing pregnancy Rate
Pregnancies continued beyond 20 weeks gestation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: